Results
|
1481.
|
|
|
1482.
|
|
|
1483.
|
|
|
1484.
|
|
|
1485.
|
|
|
1486.
|
|
|
1487.
|
|
|
1488.
|
|
|
1489.
|
|
|
1490.
|
|
|
1491.
|
|
|
1492.
|
|
|
1493.
|
|
|
1494.
|
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia. [electronic resource] by
- Sopper, Sieghart
- Mustjoki, Satu
- White, Deborah
- Hughes, Timothy
- Valent, Peter
- Burchert, Andreas
- Gjertsen, Bjørn T
- Gastl, Günther
- Baldauf, Matthias
- Trajanoski, Zlatko
- Giles, Frank
- Hochhaus, Andreas
- Ernst, Thomas
- Schenk, Thomas
- Janssen, Jeroen J W M
- Ossenkoppele, Gert J
- Porkka, Kimmo
- Wolf, Dominik
Producer: 20170821
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
1495.
|
|
|
1496.
|
|
|
1497.
|
|
|
1498.
|
|
|
1499.
|
|
|
1500.
|
|